Author: Fay Bound Alberti
Publisher: Oxford University Press
ISBN: 0191036560
Category : History
Languages : en
Pages : 285
Book Description
To many people the idea that 'the body' has its own history might sound faintly ridiculous. The body and its experiences are usually seen as something that we share with people from the past. Like 'human nature', it represents the unchanging in a changing world. Bodies just are... But the body does have a history. The way that it moves, feels, breathes, and engages with the world has been viewed very differently across times and cultures. For centuries, 'we' were believed to be composed of souls that were part of the body and inseparable from it. Now we exist in our heads, and our bodies have become the vessels for that uncertain and elusive thing we call our 'true selves'. The way we understand the material structure of the body has also changed radically over the centuries. From the bones to the skin, from the senses to the organs of sexual reproduction, every part of the body has an ever-changing history, dependent on time, culture, and place. This Mortal Coil is an exploration of that history. Peeling away our assumptions about the unchanging nature of the human body, Fay Bound Alberti takes it apart in order to put it back anew, telling the cultural history of our key organs and systems from the inside out, from blood to guts, brains to sex organs. The understanding of the 'modern body' she reveals in the process is far removed from the 'eternal' or timeless object of common assumption. In fact, she argues, its roots go back no further than the sixteenth century at the earliest - and it has only truly existed in its current form since the nineteenth century.
This Mortal Coil
EU Law
Author: Iyiola Solanke
Publisher: Cambridge University Press
ISBN: 1108831893
Category : Law
Languages : en
Pages : 703
Book Description
Provides up-to-date, accessible, and intellectually sophisticated insights on EU Law using real-life examples and current case studies.
Publisher: Cambridge University Press
ISBN: 1108831893
Category : Law
Languages : en
Pages : 703
Book Description
Provides up-to-date, accessible, and intellectually sophisticated insights on EU Law using real-life examples and current case studies.
Mass Torts in Europe
Author: Willem H. van Boom
Publisher: Walter de Gruyter GmbH & Co KG
ISBN: 3110349469
Category : Law
Languages : en
Pages : 326
Book Description
in recent years, there has been a growing interest in the legal aspects of mass torts in Europe. Both academics, legislatures, courts and policymakers throughout the whole of Europe have been struggling with the challenges that such ‚massification‘ of private law relationships poses both in and outside of tort law. The subject moves between the law of civil procedure, substantive tort law, access to justice debates and regulatory frameworks for mass disputes. This volume offers both a caleidoscopic review of real-life key cases of mass tort and an in-depth reflection on the broader implications of mass tort in Europe. Thus, the challenges posed by mass torts are explored, mapped and analysed.
Publisher: Walter de Gruyter GmbH & Co KG
ISBN: 3110349469
Category : Law
Languages : en
Pages : 326
Book Description
in recent years, there has been a growing interest in the legal aspects of mass torts in Europe. Both academics, legislatures, courts and policymakers throughout the whole of Europe have been struggling with the challenges that such ‚massification‘ of private law relationships poses both in and outside of tort law. The subject moves between the law of civil procedure, substantive tort law, access to justice debates and regulatory frameworks for mass disputes. This volume offers both a caleidoscopic review of real-life key cases of mass tort and an in-depth reflection on the broader implications of mass tort in Europe. Thus, the challenges posed by mass torts are explored, mapped and analysed.
The Routledge History of Disease
Author: Mark Jackson
Publisher: Routledge
ISBN: 113485787X
Category : History
Languages : en
Pages : 636
Book Description
The Routledge History of Disease draws on innovative scholarship in the history of medicine to explore the challenges involved in writing about health and disease throughout the past and across the globe, presenting a varied range of case studies and perspectives on the patterns, technologies and narratives of disease that can be identified in the past and that continue to influence our present. Organized thematically, chapters examine particular forms and conceptualizations of disease, covering subjects from leprosy in medieval Europe and cancer screening practices in twentieth-century USA to the ayurvedic tradition in ancient India and the pioneering studies of mental illness that took place in nineteenth-century Paris, as well as discussing the various sources and methods that can be used to understand the social and cultural contexts of disease. Chapter 24 of this book is freely available as a downloadable Open Access PDF under a Creative Commons Attribution-Non Commercial-No Derivatives 3.0 license. https://www.routledgehandbooks.com/doi/10.4324/9781315543420.ch24
Publisher: Routledge
ISBN: 113485787X
Category : History
Languages : en
Pages : 636
Book Description
The Routledge History of Disease draws on innovative scholarship in the history of medicine to explore the challenges involved in writing about health and disease throughout the past and across the globe, presenting a varied range of case studies and perspectives on the patterns, technologies and narratives of disease that can be identified in the past and that continue to influence our present. Organized thematically, chapters examine particular forms and conceptualizations of disease, covering subjects from leprosy in medieval Europe and cancer screening practices in twentieth-century USA to the ayurvedic tradition in ancient India and the pioneering studies of mental illness that took place in nineteenth-century Paris, as well as discussing the various sources and methods that can be used to understand the social and cultural contexts of disease. Chapter 24 of this book is freely available as a downloadable Open Access PDF under a Creative Commons Attribution-Non Commercial-No Derivatives 3.0 license. https://www.routledgehandbooks.com/doi/10.4324/9781315543420.ch24
Women's Health and Biomechanics
Author: Sofia Brandão
Publisher: Springer
ISBN: 3319715747
Category : Science
Languages : en
Pages : 239
Book Description
This book focuses on particular mental and physical aspects of women’s health, presenting topics concerning the pelvis and pelvic floor dysfunction and the breast during a woman’s life, such as rehabilitation for pelvic and breast disorders, and the benefits of biomechanical analysis in treating these conditions. With each chapter providing a brief survey of a major research area related to the theme, the book offers an integrated overview of topics such as the bio-psycho-social model of women’s health, pelvic floor evaluation in sports, the breast, pregnancy and delivery. It is a valuable resource for a wide range of readers, including researchers, graduates and professionals.
Publisher: Springer
ISBN: 3319715747
Category : Science
Languages : en
Pages : 239
Book Description
This book focuses on particular mental and physical aspects of women’s health, presenting topics concerning the pelvis and pelvic floor dysfunction and the breast during a woman’s life, such as rehabilitation for pelvic and breast disorders, and the benefits of biomechanical analysis in treating these conditions. With each chapter providing a brief survey of a major research area related to the theme, the book offers an integrated overview of topics such as the bio-psycho-social model of women’s health, pelvic floor evaluation in sports, the breast, pregnancy and delivery. It is a valuable resource for a wide range of readers, including researchers, graduates and professionals.
PIP breast implants and regulation of cosmetic interventions
Author: Great Britain: Parliament: House of Commons: Health Committee
Publisher: The Stationery Office
ISBN: 9780215043474
Category : Medical
Languages : en
Pages : 60
Book Description
The Health Committee welcomes the Government's decision to commission two reviews following public concern about breast implant surgery, following the decision of the French authorities to recommend removal of implants sourced from PIP. The first, led by Sir Bruce Keogh, is tasked with assessing the regulation of cosmetic interventions in general. The second, led by Earl Howe, is tasked with analysing the policy reaction, in particular by MHRA and DoH, to the announcement by the French authorities in March 2010 that PIP products did not comply with the requirements of their CE registration. Sir Bruce 's preliminary report concluded that there is no evidence of likely long term negative health effects attributable to PIP implants, though the quality of evidence available does not allow definitive conclusions to be drawn. The Committee welcomes the Government's undertaking that the NHS will remove and replace any NHS implant which has failed, and agrees with the Government that all other care providers should make the same offer. The cost of all care provided in respect of non-NHS implants should be recovered, where possible, from the original care provider, or their insurers. Earl Howe's review should focus on key policy issues: the quality of information available about devices that have been implanted into patients; evidence that MRHA notices withdrawing CE registration from individual products do not require any positive response from non-NHS users of those products; evidence that some patients may have received implants without being fully aware of the medium and long term consequences.
Publisher: The Stationery Office
ISBN: 9780215043474
Category : Medical
Languages : en
Pages : 60
Book Description
The Health Committee welcomes the Government's decision to commission two reviews following public concern about breast implant surgery, following the decision of the French authorities to recommend removal of implants sourced from PIP. The first, led by Sir Bruce Keogh, is tasked with assessing the regulation of cosmetic interventions in general. The second, led by Earl Howe, is tasked with analysing the policy reaction, in particular by MHRA and DoH, to the announcement by the French authorities in March 2010 that PIP products did not comply with the requirements of their CE registration. Sir Bruce 's preliminary report concluded that there is no evidence of likely long term negative health effects attributable to PIP implants, though the quality of evidence available does not allow definitive conclusions to be drawn. The Committee welcomes the Government's undertaking that the NHS will remove and replace any NHS implant which has failed, and agrees with the Government that all other care providers should make the same offer. The cost of all care provided in respect of non-NHS implants should be recovered, where possible, from the original care provider, or their insurers. Earl Howe's review should focus on key policy issues: the quality of information available about devices that have been implanted into patients; evidence that MRHA notices withdrawing CE registration from individual products do not require any positive response from non-NHS users of those products; evidence that some patients may have received implants without being fully aware of the medium and long term consequences.
Pharmaceutical and Medical Device Safety
Author: Sonia Macleod
Publisher: Bloomsbury Publishing
ISBN: 1509916733
Category : Law
Languages : en
Pages : 321
Book Description
This book examines how regulatory and liability mechanisms have impacted upon product safety decisions in the pharmaceutical and medical devices sectors in Europe, the USA and beyond since the 1950s. Thirty-five case studies illustrate the interplay between the regulatory regimes and litigation. Observations from medical practice have been the overwhelming means of identifying post-marketing safety issues. Drug and device safety decisions have increasingly been taken by public regulators and companies within the framework of the comprehensive regulatory structure that has developed since the 1960s. In general, product liability cases have not identified or defined safety issues, and function merely as compensation mechanisms. This is unsurprising as the thresholds for these two systems differ considerably; regulatory action can be triggered by the possibility that a product might be harmful, whereas establishing liability in litigation requires proving that the product was actually harmful. As litigation normally post-dates regulatory implementation, the 'private enforcement' of public law has generally not occurred in these sectors. This has profound implications for the design of sectoral regulatory and liability regimes, including associated features such as extended liability law, class actions and contingency fees. This book forms a major contribution to the academic debate on the comparative utility of regulatory and liability systems, on public versus private enforcement, and on mechanisms of behaviour control.
Publisher: Bloomsbury Publishing
ISBN: 1509916733
Category : Law
Languages : en
Pages : 321
Book Description
This book examines how regulatory and liability mechanisms have impacted upon product safety decisions in the pharmaceutical and medical devices sectors in Europe, the USA and beyond since the 1950s. Thirty-five case studies illustrate the interplay between the regulatory regimes and litigation. Observations from medical practice have been the overwhelming means of identifying post-marketing safety issues. Drug and device safety decisions have increasingly been taken by public regulators and companies within the framework of the comprehensive regulatory structure that has developed since the 1960s. In general, product liability cases have not identified or defined safety issues, and function merely as compensation mechanisms. This is unsurprising as the thresholds for these two systems differ considerably; regulatory action can be triggered by the possibility that a product might be harmful, whereas establishing liability in litigation requires proving that the product was actually harmful. As litigation normally post-dates regulatory implementation, the 'private enforcement' of public law has generally not occurred in these sectors. This has profound implications for the design of sectoral regulatory and liability regimes, including associated features such as extended liability law, class actions and contingency fees. This book forms a major contribution to the academic debate on the comparative utility of regulatory and liability systems, on public versus private enforcement, and on mechanisms of behaviour control.
Practical Toxicology
Author: David Woolley
Publisher: CRC Press
ISBN: 1498709303
Category : Medical
Languages : en
Pages : 553
Book Description
Practical Toxicology: Evaluation, Prediction, and Risk, Third Edition shows how to conduct a program of safety evaluation and testing and then to interpret and apply the resulting data and information in the real world, beginning with the basic concepts in toxicology and progressing to the interpretation of the resulting data. Revised and updated chapters on risk assessment guide the reader to setting the foundations necessary for submission to regulatory authorities. In addition, a new chapter in the book reviews the errors in toxicology, mistakes, misuse, mismanagement, and misunderstanding with a view to avoiding these in the future. New Chapters in the Third Edition: Toxicology in silico Errors in Toxicology Safety Assessment of Extractables and Leachables. This new edition follows a practical sequence from introducing the basics of toxicology (including the vital concept of normality in controls) to describing a test program and then interpreting the data and translating that to risk assessment that can be used in a number of real world situations where safety and secure risk assessment are essential. Although written primarily from the perspective of pharmaceutical development, the test designs and toxicological problems encountered in that field are entirely relevant to those with other classes of chemicals, the only difference being the regulatory context. Toxicology is an international discipline and the book has been written to take into account some of the differences in regulatory nuance between the main regions of the world. Completely revised and written in an easily accessible style, the text address several audiences—from students and post-graduates coming to the subject for the first time to established professionals who find themselves needing to learn about toxicology, toxicity testing, interpretation of the results, and risk assessment. It is intended primarily as a textbook, with case studies and information on where to go to ask questions, but can also be used as a practical reference book. It covers all the basics of toxicology and the main aspects of safety evaluation testing and risk assessment while reviewing critically the current state of the discipline. It also provides a foundation for those seeking registration or certification.
Publisher: CRC Press
ISBN: 1498709303
Category : Medical
Languages : en
Pages : 553
Book Description
Practical Toxicology: Evaluation, Prediction, and Risk, Third Edition shows how to conduct a program of safety evaluation and testing and then to interpret and apply the resulting data and information in the real world, beginning with the basic concepts in toxicology and progressing to the interpretation of the resulting data. Revised and updated chapters on risk assessment guide the reader to setting the foundations necessary for submission to regulatory authorities. In addition, a new chapter in the book reviews the errors in toxicology, mistakes, misuse, mismanagement, and misunderstanding with a view to avoiding these in the future. New Chapters in the Third Edition: Toxicology in silico Errors in Toxicology Safety Assessment of Extractables and Leachables. This new edition follows a practical sequence from introducing the basics of toxicology (including the vital concept of normality in controls) to describing a test program and then interpreting the data and translating that to risk assessment that can be used in a number of real world situations where safety and secure risk assessment are essential. Although written primarily from the perspective of pharmaceutical development, the test designs and toxicological problems encountered in that field are entirely relevant to those with other classes of chemicals, the only difference being the regulatory context. Toxicology is an international discipline and the book has been written to take into account some of the differences in regulatory nuance between the main regions of the world. Completely revised and written in an easily accessible style, the text address several audiences—from students and post-graduates coming to the subject for the first time to established professionals who find themselves needing to learn about toxicology, toxicity testing, interpretation of the results, and risk assessment. It is intended primarily as a textbook, with case studies and information on where to go to ask questions, but can also be used as a practical reference book. It covers all the basics of toxicology and the main aspects of safety evaluation testing and risk assessment while reviewing critically the current state of the discipline. It also provides a foundation for those seeking registration or certification.
Breast Imaging: The Requisites E-Book
Author: Debra Ikeda
Publisher: Elsevier Health Sciences
ISBN: 0323391575
Category : Medical
Languages : en
Pages : 513
Book Description
Now in its 3rd Edition, this bestselling volume in the popular Requisites series, by Drs. Debra M. Ikeda and Kanae K. Miyake, thoroughly covers the fast-changing field of breast imaging. Ideal for residency, clinical practice and certification and MOC exam study, it presents everything you need to know about diagnostic imaging of the breast, including new BI-RADS standards, new digital breast tomosynthesis (DBT) content, ultrasound, and much more. Compact and authoritative, it provides up-to-date, expert guidance in reading and interpreting mammographic, ultrasound, DBT, and MRI images for efficient and accurate detection of breast disease. Features over 1,300 high-quality images throughout. Summarizes key information with numerous outlines, tables, ''pearls,'' and boxed material for easy reference. Focuses on essentials to pass the boards and the MOC exam and ensure accurate diagnoses in clinical practice. Consult this title on your favorite e-reader, conduct rapid searches, and adjust font sizes for optimal readability. All-new Breast Imaging-Reporting and Data System (BI-RADS) recommendations for management and terminology for mammography, elastography in ultrasound, and MRI. Step-by-step guidance on how to read new 3D tomosynthesis imaging studies with example cases, including limitations, pitfalls, and 55 new DBT videos. More evidence on the management of high risk breast lesions. Correlations of ultrasound, mammography, and MRI with tomosynthesis imaging. Detailed basis of contrast-enhanced MRI studies. Recent nuclear medicine techniques such as FDG PET/CT, NaF PET.
Publisher: Elsevier Health Sciences
ISBN: 0323391575
Category : Medical
Languages : en
Pages : 513
Book Description
Now in its 3rd Edition, this bestselling volume in the popular Requisites series, by Drs. Debra M. Ikeda and Kanae K. Miyake, thoroughly covers the fast-changing field of breast imaging. Ideal for residency, clinical practice and certification and MOC exam study, it presents everything you need to know about diagnostic imaging of the breast, including new BI-RADS standards, new digital breast tomosynthesis (DBT) content, ultrasound, and much more. Compact and authoritative, it provides up-to-date, expert guidance in reading and interpreting mammographic, ultrasound, DBT, and MRI images for efficient and accurate detection of breast disease. Features over 1,300 high-quality images throughout. Summarizes key information with numerous outlines, tables, ''pearls,'' and boxed material for easy reference. Focuses on essentials to pass the boards and the MOC exam and ensure accurate diagnoses in clinical practice. Consult this title on your favorite e-reader, conduct rapid searches, and adjust font sizes for optimal readability. All-new Breast Imaging-Reporting and Data System (BI-RADS) recommendations for management and terminology for mammography, elastography in ultrasound, and MRI. Step-by-step guidance on how to read new 3D tomosynthesis imaging studies with example cases, including limitations, pitfalls, and 55 new DBT videos. More evidence on the management of high risk breast lesions. Correlations of ultrasound, mammography, and MRI with tomosynthesis imaging. Detailed basis of contrast-enhanced MRI studies. Recent nuclear medicine techniques such as FDG PET/CT, NaF PET.
Regulation of Medical Implants in the EU and UK
Author: Great Britain: Parliament: House of Commons: Science and Technology Committee
Publisher: The Stationery Office
ISBN: 9780215049742
Category : Medical
Languages : en
Pages : 110
Book Description
EU regulations on the safety of medical implants-such as metal-on-metal hip replacements-must be urgently tightened in response to evidence that manufacturers are seeking approval for devices in Member States with the least stringent regulatory regimes. Much greater transparency is needed about the approval process so patients and doctors can have full confidence in the implants they are using. Manufacturers and regulators must also publish more rigorous clinical data on the safety of new implants and be subject to greater scrutiny. The clinical data requirements for high-risk medical devices to be sold on the European Market are much less stringent than for new medicines. There appears to be reliance on equivalence-similarity to an existing implant-rather than clinical investigations of the implant being approved. The Committee calls for all clinical data used in the approval of a medical implant to be published without identifying patients or clinical trial participants. For products currently on the market, such data should be published immediately. There should also be a public record of every approach from a manufacturer to any notified body in the EU so that 'forum shopping' can be identified. UK regulatory body the Medicines and Healthcare products Regulatory Agency (MHRA) is criticised for its slow reaction to reports of problems with metal-on-metal hip replacements in Australia. The withdrawal of PIP breast implants also highlights the need for frequent and unannounced spot-checks of medical implant manufacturers to identify and prevent similar problems. The Committee is supportive of the proposed legislative changes from the European Commission to improve transparency
Publisher: The Stationery Office
ISBN: 9780215049742
Category : Medical
Languages : en
Pages : 110
Book Description
EU regulations on the safety of medical implants-such as metal-on-metal hip replacements-must be urgently tightened in response to evidence that manufacturers are seeking approval for devices in Member States with the least stringent regulatory regimes. Much greater transparency is needed about the approval process so patients and doctors can have full confidence in the implants they are using. Manufacturers and regulators must also publish more rigorous clinical data on the safety of new implants and be subject to greater scrutiny. The clinical data requirements for high-risk medical devices to be sold on the European Market are much less stringent than for new medicines. There appears to be reliance on equivalence-similarity to an existing implant-rather than clinical investigations of the implant being approved. The Committee calls for all clinical data used in the approval of a medical implant to be published without identifying patients or clinical trial participants. For products currently on the market, such data should be published immediately. There should also be a public record of every approach from a manufacturer to any notified body in the EU so that 'forum shopping' can be identified. UK regulatory body the Medicines and Healthcare products Regulatory Agency (MHRA) is criticised for its slow reaction to reports of problems with metal-on-metal hip replacements in Australia. The withdrawal of PIP breast implants also highlights the need for frequent and unannounced spot-checks of medical implant manufacturers to identify and prevent similar problems. The Committee is supportive of the proposed legislative changes from the European Commission to improve transparency